Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Join SI Premium – FREE
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q3 EPS of ($0.06), $0.04 better than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Altman: AI Has More Of A Science Problem Than Engineering
- Lundbeck said to explore acquisition of Xeris Biopharma - Bloomberg
- Apple's New CEO Moves To Overhaul Company To Run Faster, Leaner - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
